CII
ABMD

CR Intrinsic Investors’s Abiomed Inc ABMD Stock Holding History

CR Intrinsic Investors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-100,000
Closed -$2.16M – 418
2013
Q2 		$2.16M Buy
+100,000
New +$2.01M 0.07% 267

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

CR Intrinsic Investors's ABMD Position: Q3 2013 in Review

CR Intrinsic Investors sold out of Abiomed Inc (ABMD) in Q3 2013, closing a stake of 100,000 shares — an estimated $2.16M sold.

CR Intrinsic Investors first reported a position in ABMD in Q2 2013 and held it in 1 quarter. The position peaked at $2.16M in Q2 2013. 122 funds tracked by Wall St. Rank hold ABMD as of Q3 2013.

  • CR Intrinsic Investors reported no remaining Abiomed Inc position as of Q3 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 100,000 Abiomed Inc shares in Q3 2013, an estimated $2.16M.
  • CR Intrinsic Investors first reported a position in Abiomed Inc in Q2 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's Abiomed Inc position peaked at $2.16M in Q2 2013.
  • 122 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2013.

Based on CR Intrinsic Investors's 13F filing for Q3 2013, filed 14 Nov 2013.